Universal Biosensors (ASX:UBI) Debt-to-Equity : 0.26 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Universal Biosensors Debt-to-Equity?

Universal Biosensors's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.75 Mil. Universal Biosensors's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$3.23 Mil. Universal Biosensors's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$19.51 Mil. Universal Biosensors's debt to equity for the quarter that ended in Dec. 2023 was 0.25.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Universal Biosensors's Debt-to-Equity or its related term are showing as below:

ASX:UBI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.08 Med: 0.58 Max: 1.56
Current: 0.26

During the past 13 years, the highest Debt-to-Equity Ratio of Universal Biosensors was 1.56. The lowest was 0.08. And the median was 0.58.

ASX:UBI's Debt-to-Equity is ranked worse than
55.01% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs ASX:UBI: 0.26

Universal Biosensors Debt-to-Equity Historical Data

The historical data trend for Universal Biosensors's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Biosensors Debt-to-Equity Chart

Universal Biosensors Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.11

0.08

0.19

0.26

Universal Biosensors Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.19	0.24	0.21	0.21	0.26

Competitive Comparison of Universal Biosensors's Debt-to-Equity

For the Medical Devices subindustry, Universal Biosensors's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Biosensors's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Universal Biosensors's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Universal Biosensors's Debt-to-Equity falls into.

Universal Biosensors Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Universal Biosensors's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.746	+	3.226)	/	19.508
	=	0.25

Universal Biosensors's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.746	+	3.226)	/	19.508
	=	0.25

Universal Biosensors (ASX:UBI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Universal Biosensors Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Universal Biosensors's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Biosensors (ASX:UBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Universal Biosensors Inc (ASX:UBI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Corporate Avenue, Rowville, VIC, AUS, 3178

Website

https://www.universalbiosensors.com

Universal Biosensors Inc is a developer of biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in its hand-held portable analysers for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture, enabling high speed, ease of use, reliability, accuracy at low cost.

Universal Biosensors (ASX:UBI) Headlines

No Headlines